Koichi Sughimoto1,2, Kagami Miyaji3, Norihiko Oka3, Shinzo Torii3, Tadashi Kitamura3. 1. Department of Cardiovascular Surgery, Kitasato University School of Medicine, 1-15-1, Kitasato, Minami-ward, Sagamihara, Japan. ksughimoto@gmail.com. 2. Division of Pediatric Cardiothoracic Surgery, British Columbia Children's Hospital, 4480 Oak Street, Vancouver, Canada. ksughimoto@gmail.com. 3. Department of Cardiovascular Surgery, Kitasato University School of Medicine, 1-15-1, Kitasato, Minami-ward, Sagamihara, Japan.
Abstract
OBJECTIVES: Although primary sutureless technique for total anomalous pulmonary venous drainage has been introduced to reduce postoperative pulmonary vein obstruction (PVO), controversy still exists about superiority of the procedure between the conventional repair and primary sutureless technique at the initial repair. In our unit, the conventional repair has been consistently used based on four important surgical policies: (1) mark incision lines between 2 chambers to gain anatomically natural alignment, (2) place precise stitches by "intima-to-intima" using monofilament suture, (3) adequate orifice size should be guaranteed in greater than expected mitral valve size, (4) do not hesitate to undertake a redo additional anastomosis by a different approach when an echocardiography shows the velocity more than 1.5 m/s. This study aims to evaluate mid-term outcome of the conventional repair for total anomalous pulmonary venous drainage. METHODS: Between 2004 and 2016, consecutive 15 patients who underwent the conventional repair without the primary sutureless technique were included in this study. Survival, Freedom from reoperation, and PVO were retrospectively reviewed. RESULTS: Mean follow-up period was 4.6 ± 3.7 years. Except for one patient who died of uncontrollable pleural effusion, all other patients survived with 5-year survival rate of 93.3%. For the 14 survivors, there was no PVO, nor reoperation. CONCLUSIONS: Following these policies, the mid-term outcome of the conventional total anomalous pulmonary venous drainage repair was excellent without the primary sutureless technique showing no obstruction. The conventional repair can be safely applied at the initial operation when the morphological condition allows for it.
OBJECTIVES: Although primary sutureless technique for total anomalous pulmonary venous drainage has been introduced to reduce postoperative pulmonary vein obstruction (PVO), controversy still exists about superiority of the procedure between the conventional repair and primary sutureless technique at the initial repair. In our unit, the conventional repair has been consistently used based on four important surgical policies: (1) mark incision lines between 2 chambers to gain anatomically natural alignment, (2) place precise stitches by "intima-to-intima" using monofilament suture, (3) adequate orifice size should be guaranteed in greater than expected mitral valve size, (4) do not hesitate to undertake a redo additional anastomosis by a different approach when an echocardiography shows the velocity more than 1.5 m/s. This study aims to evaluate mid-term outcome of the conventional repair for total anomalous pulmonary venous drainage. METHODS: Between 2004 and 2016, consecutive 15 patients who underwent the conventional repair without the primary sutureless technique were included in this study. Survival, Freedom from reoperation, and PVO were retrospectively reviewed. RESULTS: Mean follow-up period was 4.6 ± 3.7 years. Except for one patient who died of uncontrollable pleural effusion, all other patients survived with 5-year survival rate of 93.3%. For the 14 survivors, there was no PVO, nor reoperation. CONCLUSIONS: Following these policies, the mid-term outcome of the conventional total anomalous pulmonary venous drainage repair was excellent without the primary sutureless technique showing no obstruction. The conventional repair can be safely applied at the initial operation when the morphological condition allows for it.
Entities:
Keywords:
Congenital heart disease; Total anomalous pulmonary venous drainage
Authors: Nicola Viola; Abdullah A Alghamdi; Donald G Perrin; Gregory J Wilson; John G Coles; Christopher A Caldarone Journal: J Thorac Cardiovasc Surg Date: 2011-02-01 Impact factor: 5.209
Authors: Osami Honjo; Cori R Atlin; Barbara C S Hamilton; Osman Al-Radi; Nicola Viola; John G Coles; Glen S Van Arsdell; Christopher A Caldarone Journal: Ann Thorac Surg Date: 2010-09 Impact factor: 4.330
Authors: Anna N Seale; Hideki Uemura; Steven A Webber; John Partridge; Michael Roughton; Siew Y Ho; Karen P McCarthy; Sheila Jones; Lynda Shaughnessy; Jan Sunnegardh; Katarina Hanseus; Hakan Berggren; Sune Johansson; Michael L Rigby; Barry R Keeton; Piers E F Daubeney Journal: J Thorac Cardiovasc Surg Date: 2012-08-11 Impact factor: 5.209
Authors: Anna N Seale; Hideki Uemura; Steven A Webber; John Partridge; Michael Roughton; Siew Y Ho; Karen P McCarthy; Sheila Jones; Lynda Shaughnessy; Jan Sunnegardh; Katarina Hanseus; Hakan Berggren; Sune Johansson; Michael L Rigby; Barry R Keeton; Piers E F Daubeney Journal: Circulation Date: 2010-12-06 Impact factor: 29.690
Authors: Bobby Yanagawa; Abdullah A Alghamdi; Andreea Dragulescu; Nicola Viola; Osman O Al-Radi; Luc L Mertens; John G Coles; Christopher A Caldarone; Glen S Van Arsdell Journal: J Thorac Cardiovasc Surg Date: 2011-03-31 Impact factor: 5.209
Authors: S Adil Husain; Elaine Maldonado; Debbie Rasch; Joel Michalek; Richard Taylor; Christopher Curzon; Steve Neish; John H Calhoon Journal: Ann Thorac Surg Date: 2012-05-24 Impact factor: 4.330
Authors: Tae-Jin Yun; John G Coles; Igor E Konstantinov; Osman O Al-Radi; Rachel M Wald; Vitor Guerra; Nilto C de Oliveira; Glen S Van Arsdell; William G Williams; Jeffrey Smallhorn; Christopher A Caldarone Journal: J Thorac Cardiovasc Surg Date: 2005-01 Impact factor: 5.209